PulmOne

Desktop Device for Pulmonary Function Testing

Health Tech & Life Sciences
Active
Series A Ra'anana Founded 2006
Total raised
$13.7M
Last: Convertible Debt 2022-03
Stage
Series A
Founded
2006
Headcount
53
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

PulmOne develops patient-friendly, hassle-free, and budget-conscious devices designed to accurately inform clinical decision making throughout the diagnosis, treatment, and monitoring of respiratory diseases. The company's MiniBox is a system for measuring lung volume and spirometry. It is a desktop device designed to provide an accurate assessment of lung volume based on normal tidal breathing and a short measurement time. The system does not rely on a plethysmograph or external gas source. PulmOne's MiniBox+ adds to the spirometry and LVM tests with a diffusing capacity (DLCO) module, providing a complete solution. The company has received FDA 510k clearance and a CE mark for its first product and started sales in several locations.

Funding history · 5 rounds · $13.7M total

2022-03
Convertible Debt $4.0M
2021-12
Convertible Debt $4.0M
2017-06
Series A $1.2M
2015-04
Series A $2.8M
2013-05
Series A $1.6M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is PulmOne's primary product offering?
PulmOne's primary product is the MiniBox, a desktop device for measuring lung volume and spirometry. The company also offers the MiniBox+, which includes a diffusing capacity (DLCO) module for a complete pulmonary function testing solution.
When was PulmOne founded?
PulmOne was founded in March 2006.
What regulatory clearances has PulmOne received for its products?
PulmOne has received FDA 510k clearance and a CE mark for its first product, enabling sales in various locations.
What is the total amount of funding PulmOne has raised?
PulmOne has raised a total of $13,709,406 across multiple funding rounds. For a full financing history, please refer to startupim.
Which investors have participated in PulmOne's funding rounds?
OurCrowd has been a consistent investor in PulmOne's Series A and Convertible Debt rounds. Alpha LTI also participated as a lead investor in a Convertible Debt round in December 2021.
Where are PulmOne's main offices located?
PulmOne's headquarters are in Ra'anana, Israel, and they also have an office in New York, USA.
What is the employee count for PulmOne?
PulmOne has 53 employees, falling within the 51-200 employee range.
What was PulmOne's most recent funding round?
PulmOne's most recent funding round was a Convertible Debt round in March 2022, which raised $4,000,000.
What is the purpose of PulmOne's MiniBox+ system?
The MiniBox+ system from PulmOne expands on the MiniBox's spirometry and lung volume measurement capabilities by adding a diffusing capacity (DLCO) module, providing a comprehensive solution for pulmonary function testing.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDiagnostics Devices
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 Patents

Tags

hospitalspulmonarydiagnosticsmedical-devicesmonitoringrespiratorydoctorspatent-pendinghealthcare-providersclinics